Cellink Relaunches Real-Time qPCR Instrument for COVID-19
By LabMedica International staff writers Posted on 04 Apr 2020 |
Illustration
CELLINK (Boston, MA, USA) has begun reselling its qPCR instrument which can be used for the quantification and genotyping of human viral pathogens, such as SARS-CoV-2. CELLINK is offering the instrument at a low-cost point to help advance research related to the COVID-19 pandemic and provide scientists with the tools they need to make a difference.
CELLINK is a niche life-science company that develops and delivers life-science solutions for cell culturing. It focuses on three application areas, including bioprinting, analysis and liquid handling & bioprocessing to deliver a complete solution in its life science niche. The company targets to develop and commercialize cell culture technologies, enabling researchers to print human organs and tissues for pharmaceutical and cosmetic applications.
CELLINK’s qPCR instrument for the quantification and genotyping of human viral pathogens, such as SARS-CoV-2, uses a laboratory technique of molecular biology based on the polymerase chain reaction. It monitors the amplification of a targeted DNA molecule during the PCR (i.e., in real time). The instrument includes dual channels and is open source, allowing users to use any kit to run their samples. It is designed as a high-quality, low-throughput qPCR cycler. The instrument is easy to use and runs a sample in 20-40 minutes.
Related Links:
CELLINK
CELLINK is a niche life-science company that develops and delivers life-science solutions for cell culturing. It focuses on three application areas, including bioprinting, analysis and liquid handling & bioprocessing to deliver a complete solution in its life science niche. The company targets to develop and commercialize cell culture technologies, enabling researchers to print human organs and tissues for pharmaceutical and cosmetic applications.
CELLINK’s qPCR instrument for the quantification and genotyping of human viral pathogens, such as SARS-CoV-2, uses a laboratory technique of molecular biology based on the polymerase chain reaction. It monitors the amplification of a targeted DNA molecule during the PCR (i.e., in real time). The instrument includes dual channels and is open source, allowing users to use any kit to run their samples. It is designed as a high-quality, low-throughput qPCR cycler. The instrument is easy to use and runs a sample in 20-40 minutes.
Related Links:
CELLINK
Latest COVID-19 News
- New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
- Long COVID Etiologies Found in Acute Infection Blood Samples
- Novel Device Detects COVID-19 Antibodies in Five Minutes
- CRISPR-Powered COVID-19 Test Detects SARS-CoV-2 in 30 Minutes Using Gene Scissors
- Gut Microbiome Dysbiosis Linked to COVID-19
- Novel SARS CoV-2 Rapid Antigen Test Validated for Diagnostic Accuracy
- New COVID + Flu + R.S.V. Test to Help Prepare for `Tripledemic`
- AI Takes Guesswork Out Of Lateral Flow Testing
- Fastest Ever SARS-CoV-2 Antigen Test Designed for Non-Invasive COVID-19 Testing in Any Setting
- Rapid Antigen Tests Detect Omicron, Delta SARS-CoV-2 Variants
- Health Care Professionals Showed Increased Interest in POC Technologies During Pandemic, Finds Study
- Set Up Reserve Lab Capacity Now for Faster Response to Next Pandemic, Say Researchers
- Blood Test Performed During Initial Infection Predicts Long COVID Risk
- Low-Cost COVID-19 Testing Platform Combines Sensitivity of PCR and Speed of Antigen Tests
- Finger-Prick Blood Test Identifies Immunity to COVID-19
- Quick Test Kit Determines Immunity Against COVID-19 and Its Variants